Adenocyte
Israel, Haifa and Jerusalem, Israel
About Adenocyte
Adenocyte is an Israeli medical technology company developing the LINFU platform, which combines microbubble injection with low-intensity non-focused ultrasound to safely release epithelial cells for cytological analysis of the pancreas, breast, and prostate. Its FDA-cleared technology targets very early detection of pancreatic cancer in high-risk patients and is reimbursed by Medicare and commercial insurers under existing CPT codes.
Latest Funding
Series AAnnounced 2026-05-26
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
4 signals · where the capital is going
Clinical expansion of the LINFU pancreatic screening platform across additional U.S. endoscopy and pancreatic centers.
https://www.newswire.ca/news-releases/igan-partners-invests-in-adenocyte-ltd-to-advance-the-early-detection-of-pancreatic-cancer-863949677.html
Scale Quest Diagnostics / AmeriPath laboratory processing capacity for LINFU-enhanced pancreatic cytology samples.
https://www.newswire.ca/news-releases/igan-partners-invests-in-adenocyte-ltd-to-advance-the-early-detection-of-pancreatic-cancer-863949677.html
+2 more capital deployment signals · confidence ratings · source articles
Sign up freeIn the news
Selling to Adenocyte? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Adenocyte.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of Adenocyte, and who are their main competitors?
Sign up free to ask AI about Adenocyte
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
iGan Partners
Lead investor · Series A
Tech Stack
Google Cloud
Lodash
Wix
Key Highlights
AI InsightsiGan Partners led the first close of a $10M round; the final close is expected in June 2026.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Adenocyte
Selling to Adenocyte? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Adenocyte.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.